Lee Bowman

1.1k total citations
40 papers, 817 citations indexed

About

Lee Bowman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Lee Bowman has authored 40 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 9 papers in Economics and Econometrics. Recurrent topics in Lee Bowman's work include Advanced Breast Cancer Therapies (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Lee Bowman is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Lee Bowman collaborates with scholars based in United States, United Kingdom and France. Lee Bowman's co-authors include Kristina S. Boye, Jennifer Flynn, Louis S. Matza, Alistair Royse, David Canty, Colin Royse, Thomas Kilpatrick, Lori Frank, Teresa E. Seeman and Ase Sewall and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lee Bowman

37 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Bowman United States	15	195	178	172	112	111	40	817
Rachel Burman United Kingdom	27	116 0.6×	151 0.8×	263 1.5×	189 1.7×	47 0.4×	40	2.0k
Julie Bernier Canada	17	160 0.8×	93 0.5×	226 1.3×	40 0.4×	52 0.5×	30	1.1k
Julie Birt United States	22	226 1.2×	214 1.2×	83 0.5×	40 0.4×	46 0.4×	61	1.2k
Luís Lizán Spain	19	210 1.1×	174 1.0×	125 0.7×	88 0.8×	34 0.3×	94	1.2k
Carla DeMuro United States	16	280 1.4×	88 0.5×	146 0.8×	130 1.2×	111 1.0×	65	1.1k
Diana Rofail United States	16	89 0.5×	195 1.1×	161 0.9×	34 0.3×	40 0.4×	43	1.2k
Gregor Liegl Germany	17	112 0.6×	168 0.9×	103 0.6×	271 2.4×	104 0.9×	53	977
Sara N. Edmond United States	19	62 0.3×	123 0.7×	184 1.1×	237 2.1×	110 1.0×	51	1.1k
Sayuri Wada Japan	6	80 0.4×	87 0.5×	126 0.7×	54 0.5×	102 0.9×	6	1.0k
Daisy Gaunt United Kingdom	17	278 1.4×	242 1.4×	317 1.8×	27 0.2×	37 0.3×	52	1.3k

Countries citing papers authored by Lee Bowman

Since Specialization

Citations

This map shows the geographic impact of Lee Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Bowman more than expected).

Fields of papers citing papers by Lee Bowman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Bowman. The network helps show where Lee Bowman may publish in the future.

Co-authorship network of co-authors of Lee Bowman

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Bowman. A scholar is included among the top collaborators of Lee Bowman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Bowman. Lee Bowman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bowman, Lee, et al.. (2024). Quality of life analysis in patients with retinitis pigmentosa. Ophthalmic Research. 67(1). 348–357. 4 indexed citations

Rao, Xi, Emily Nash Smyth, Lacey M. Litchfield, et al.. (2023). Clinical and Genomic Characteristics of Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors. Clinical Cancer Research. 29(17). 3372–3383. 11 indexed citations

Smyth, Emily Nash, Ramón V. Tiu, Melinda D. Willard, et al.. (2023). Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States. The Oncologist. 28(11). e1075–e1091. 6 indexed citations

Kruse, Megan, Emily Nash Smyth, Lee Bowman, et al.. (2023). Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world. Breast Cancer Research and Treatment. 201(1). 105–115. 6 indexed citations

Bowman, Lee, Ramón V. Tiu, Emily Nash Smyth, et al.. (2020). Clinical Characteristics, Treatments, and Concurrent Mutations in Non–Small Cell Lung Cancer Patients With NF1 Mutations. Clinical Lung Cancer. 22(1). 32–41.e1. 7 indexed citations

Gable, Julia, David W. Ayer, Allicia C. Girvan, et al.. (2018). PCN366 - QUALITATIVE PATIENT INTERVIEWS TO SUPPORT THE FACT HEPATOBILIARY SYMPTOM INDEX-8 AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ELEVATED BASELINE ALPHA-FETOPROTEIN. Value in Health. 21. S76–S76. 1 indexed citations

Ainsworth, Claire, et al.. (2016). “Causal Cascade” Among Outcomes in Non-Small Cell Lung Cancer: Assessing The Direct and Indirect Effects of Symptoms on Health-Related Quality of Life (HRQL) Outcomes. Value in Health. 19(7). A748–A748. 1 indexed citations

Smyth, Emily Nash, Wei Shen, Lee Bowman, et al.. (2016). Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health and Quality of Life Outcomes. 14(1). 52–52. 29 indexed citations

Smyth, Emily Nash, et al.. (2015). Treatment Patterns and Health Care Resource use (Hcru) Associated with Repeatedly Treated Metastatic Squamous Cell Carcinoma of the Head and Neck (Scchn) in the United Kingdom (Uk). Value in Health. 18(7). A450–A451. 1 indexed citations

10.

Matza, Louis S., Kristina S. Boye, David Feeny, et al.. (2014). Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions. Health and Quality of Life Outcomes. 12(1). 48–48. 21 indexed citations

11.

Gilden, Daniel, Joanna Kubisiak, Kristin Kahle‐Wrobleski, Daniel Ball, & Lee Bowman. (2014). Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer’s disease patients. BMC Health Services Research. 14(1). 291–291. 22 indexed citations

12.

Swinburn, Paul, Andrew Lloyd, Kristina S. Boye, et al.. (2013). Development of a Disease-Specific Version of the EQ-5D-5L for Use in Patients Suffering from Psoriasis: Lessons Learned from a Feasibility Study in the UK. Value in Health. 16(8). 1156–1162. 85 indexed citations

13.

Canty, David, Colin Royse, Thomas Kilpatrick, Lee Bowman, & Alistair Royse. (2012). The impact of focused transthoracic echocardiography in the pre‐operative clinic. Anaesthesia. 67(6). 618–625. 83 indexed citations

14.

Mauskopf, Josephine, Costel Chirila, Kristina S. Boye, et al.. (2012). RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA. International Journal of Technology Assessment in Health Care. 29(1). 92–100. 35 indexed citations

15.

Mauskopf, Josephine, et al.. (2011). Differences among formulary submission guidelines: Implications for health technology assessment. International Journal of Technology Assessment in Health Care. 27(3). 261–270. 14 indexed citations

16.

Frank, Lori, Andrew R. Lloyd, Jennifer Flynn, et al.. (2006). Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants. International Psychogeriatrics. 18(1). 151–162. 101 indexed citations

17.

Frank, Lori, Jennifer Flynn, Leah Kleinman, et al.. (2006). Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment. International Psychogeriatrics. 18(1). 135–157. 22 indexed citations

18.

Reuben, David B., Teresa E. Seeman, Emmett B. Keeler, et al.. (2004). The Effect of Self-Reported and Performance-Based Functional Impairment on Future Hospital Costs of Community-Dwelling Older Persons. The Gerontologist. 44(3). 401–407. 29 indexed citations

19.

Marciniak, Martin, Maureen J. Lage, Ronald Landbloom, Eduardo Dunayevich, & Lee Bowman. (2004). Medical and productivity costs of anxiety disorders: Case control study. Depression and Anxiety. 19(2). 112–120. 70 indexed citations

20.

Reuben, David B., Teresa E. Seeman, Emmett B. Keeler, et al.. (2004). Refining the Categorization of Physical Functional Status: The Added Value of Combining Self-Reported and Performance-Based Measures. The Journals of Gerontology Series A. 59(10). M1056–M1061. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact